For the twelve months ended Sep 30, 2026, Healthcare Services Group Inc. reported $1.88B of revenue and $104.88M of net income.
HCSG revenue was $479.60M in fiscal Q3 2026 (ended Sep 30, 2026), up 3.3% from a year earlier and up 1.9% from the prior quarter. For the full fiscal 2025 it was $1.84B, up 7.1% from fiscal 2024. Compound annual growth was +0.9% over 5 years. It rose in 5 of the last 9 fiscal years.
HCSG net income was $24.88M in fiscal Q3 2026 (ended Sep 30, 2026), down 42.1% from a year earlier and up 9.6% from the prior quarter. For the full fiscal 2025 it was $59.06M, up 49.6% from fiscal 2024. Compound annual growth was -9.8% over 5 years and +0.2% over 10 years. It rose in 6 of the last 10 fiscal years.
HCSG diluted EPS was $0.36 in fiscal Q3 2026 (ended Sep 30, 2026), down 39.0% from a year earlier and up 12.5% from the prior quarter. For the full fiscal 2025 it was $0.81, up 52.8% from fiscal 2024. Compound annual growth was -9.3% over 5 years and +0.1% over 10 years.
HCSG free cash flow was $28.10M in fiscal Q3 2026 (ended Sep 30, 2026), down 59.8% from a year earlier and up 38.8% from the prior quarter. For the full fiscal 2025 it was $139.15M, up 468.7% from fiscal 2024. Compound annual growth was -8.2% over 5 years and +9.1% over 10 years.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.84B | $1.72B | $1.67B | $1.69B | $1.64B | $1.76B | $1.84B | $2.00B | $1.86B | $1.56B |
| Cost of revenue | $1.60B | $1.49B | $1.46B | $1.50B | $1.41B | $1.49B | $1.61B | $1.77B | $1.61B | $1.34B |
| Gross profit | $239.41M | $228.09M | $214.75M | $193.31M | $230.57M | $267.99M | $227.90M | $234.44M | $250.62M | $223.17M |
| Selling, general and admin | $190.87M | $183.06M | $166.77M | $140.34M | $173.11M | $150.78M | $150.02M | $136.60M | $126.73M | $105.42M |
| Interest expense | - | - | - | - | - | - | $3.46M | $3.09M | $1.36M | - |
| Pre-tax income | $67.87M | $52.94M | $53.06M | $44.55M | $65.51M | $129.19M | $85.10M | $99.91M | $132.97M | $120.39M |
| Income tax | $8.81M | $13.47M | $14.67M | $10.31M | $16.97M | $30.50M | $20.52M | $16.39M | $44.74M | $42.99M |
| Net income | $59.06M | $39.47M | $38.39M | $34.24M | $48.54M | $98.68M | $64.58M | $83.52M | $88.23M | $77.40M |
| EPS, basic | $0.82 | $0.54 | $0.52 | $0.46 | $0.65 | $1.32 | $0.87 | $1.13 | $1.20 | $1.06 |
| EPS, diluted | $0.81 | $0.53 | $0.52 | $0.46 | $0.65 | $1.32 | $0.87 | $1.12 | $1.19 | $1.05 |
| Diluted shares | 73.0M | 74.0M | 74.3M | 74.4M | 75.0M | 74.8M | 74.6M | 74.6M | 74.3M | 73.5M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $125.19M | $60.13M | $54.33M | $26.28M | $70.79M | $139.33M | $27.33M | $26.02M | $9.56M | $23.85M |
| Short-term investments | $42.77M | $50.53M | $93.13M | $95.20M | $114.40M | $125.01M | $90.71M | $76.36M | $73.22M | $67.73M |
| Receivables | $281.30M | $330.91M | $344.86M | - | - | - | - | - | - | - |
| Inventory | $16.80M | - | - | - | - | - | - | - | - | - |
| Current assets | $576.41M | $556.65M | $571.70M | $508.63M | $546.38M | $572.40M | $515.73M | $508.14M | $527.41M | $414.62M |
| Goodwill | $79.80M | $75.53M | $75.53M | $75.53M | $74.75M | $51.08M | $51.08M | $51.08M | $51.08M | $44.44M |
| Total assets | $794.25M | $802.77M | $790.65M | $720.84M | $779.89M | $785.03M | $722.59M | $692.60M | $676.00M | $528.45M |
| Current liabilities | $170.38M | $192.55M | $216.93M | $189.01M | $191.13M | $162.26M | $148.65M | $163.39M | $184.17M | $100.87M |
| Shareholders' equity | $510.21M | $499.93M | $456.62M | $418.28M | $445.17M | $470.28M | $460.31M | $440.78M | $399.95M | $338.84M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $144.97M | $30.80M | $43.50M | -$8.17M | $37.11M | $217.21M | $93.58M | $80.03M | $7.63M | $41.40M |
| Capital expenditures | $5.82M | $6.34M | $5.41M | $5.21M | $5.69M | $4.34M | $4.37M | $4.94M | $5.40M | $5.44M |
| Free cash flow | $139.15M | $24.47M | $38.09M | -$13.38M | $31.42M | $212.87M | $89.21M | $75.09M | $2.23M | $35.96M |
| Investing cash flow | -$11.00M | $6.05M | -$3.29M | $2.58M | -$22.99M | -$36.84M | -$16.46M | -$9.59M | -$14.97M | -$6.45M |
| Financing cash flow | -$63.33M | -$31.05M | -$12.15M | -$38.93M | -$82.65M | -$68.37M | -$75.82M | -$53.98M | -$6.96M | -$44.28M |
| Dividends paid | - | $0 | $0 | $63.37M | $62.23M | $60.70M | $58.95M | $57.20M | $55.24M | $53.34M |
| Share repurchases | $61.59M | $5.02M | $11.28M | $0 | $21.54M | $0 | $0 | - | - | - |
| Stock-based compensation | $12.01M | $9.16M | $8.98M | $9.21M | $8.83M | $7.87M | $6.87M | $5.90M | $5.99M | $4.25M |
| Depreciation and amortization | $16.78M | $14.59M | $14.34M | $15.32M | $14.67M | $14.27M | $13.94M | $9.27M | $8.89M | $7.50M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 7.1% | 2.7% | -1.1% | 2.9% | -6.7% | -4.4% | -8.1% | 7.6% | 19.1% | - |
| Net income growth, YoY | 49.6% | 2.8% | 12.1% | -29.5% | -50.8% | 52.8% | -22.7% | -5.3% | 14.0% | 33.4% |
| EPS growth, YoY | 52.8% | 1.9% | 13.0% | -29.2% | -50.8% | 51.7% | -22.3% | -5.9% | 13.3% | 31.3% |
| Gross margin | 13.0% | 13.3% | 12.8% | 11.4% | 14.0% | 15.2% | 12.4% | 11.7% | 13.5% | 14.3% |
| Net margin | 3.2% | 2.3% | 2.3% | 2.0% | 3.0% | 5.6% | 3.5% | 4.2% | 4.7% | 5.0% |
| Free cash flow margin | 7.6% | 1.4% | 2.3% | -0.8% | 1.9% | 12.1% | 4.8% | 3.7% | 0.1% | 2.3% |
| Return on equity | 11.6% | 7.9% | 8.4% | 8.2% | 10.9% | 21.0% | 14.0% | 18.9% | 22.1% | 22.8% |
| Return on assets | 7.4% | 4.9% | 4.9% | 4.8% | 6.2% | 12.6% | 8.9% | 12.1% | 13.1% | 14.6% |
| Current ratio | 3.38 | 2.89 | 2.64 | 2.69 | 2.86 | 3.53 | 3.47 | 3.11 | 2.86 | 4.11 |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $479.60M | $470.81M | $462.77M | $466.68M | $464.34M | $458.49M | $447.66M | $437.81M | $428.15M | $426.29M | $423.43M | $423.84M |
| Cost of revenue | $399.21M | $396.01M | $386.93M | $394.61M | $367.93M | $455.53M | $379.69M | $379.21M | $364.73M | $384.74M | $358.91M | $349.12M |
| Gross profit | $80.39M | $74.79M | $75.83M | $72.07M | $96.41M | $2.96M | $67.97M | $58.60M | $63.42M | $41.55M | $64.52M | $74.72M |
| Selling, general and admin | $48.45M | $52.59M | $42.00M | $46.20M | $50.54M | $49.16M | $44.97M | $44.82M | $46.89M | $44.44M | $46.91M | $46.25M |
| Pre-tax income | $33.73M | $31.00M | $34.54M | $28.55M | $57.31M | -$41.89M | $23.89M | $14.80M | $18.81M | -$1.99M | $21.31M | $32.30M |
| Income tax | $8.85M | $8.31M | $8.48M | -$2.69M | $14.36M | -$9.52M | $6.67M | $2.88M | $4.78M | -$198.0K | $6.00M | $8.79M |
| Net income | $24.88M | $22.70M | $26.06M | $31.24M | $42.95M | -$32.37M | $17.23M | $11.92M | $14.03M | -$1.79M | $15.31M | $23.51M |
| EPS, basic | $0.37 | $0.33 | $0.37 | $0.44 | $0.59 | -$0.44 | $0.23 | $0.16 | $0.19 | -$0.02 | $0.21 | $0.32 |
| EPS, diluted | $0.36 | $0.32 | $0.37 | $0.43 | $0.59 | -$0.44 | $0.23 | $0.15 | $0.19 | -$0.02 | $0.21 | $0.32 |
| Diluted shares | 69.4M | 69.9M | 71.0M | - | 73.0M | 73.2M | 74.0M | - | 73.9M | 73.9M | 74.1M | - |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $134.60M | $123.41M | $136.17M | $125.19M | $124.42M | $83.14M | $64.38M | $60.13M | $28.14M | $29.55M | $53.98M | $54.33M |
| Short-term investments | $34.22M | $41.32M | $42.44M | $42.77M | $53.07M | $51.67M | $50.50M | $50.53M | $76.78M | $79.13M | $75.62M | $93.13M |
| Receivables | $309.60M | $292.79M | $299.44M | $281.30M | $288.52M | $292.21M | $337.90M | $330.91M | - | - | - | $344.86M |
| Inventory | $15.53M | $15.84M | - | $16.80M | - | - | - | - | - | - | - | - |
| Current assets | $582.76M | $568.52M | $601.23M | $576.41M | $580.63M | $532.29M | $574.97M | $556.65M | $578.12M | $573.21M | $580.41M | $571.70M |
| Goodwill | $90.46M | $85.80M | $79.80M | $79.80M | $80.06M | $80.04M | $80.04M | $75.53M | $75.53M | $75.53M | $75.53M | $75.53M |
| Total assets | $850.40M | $820.86M | $814.85M | $794.25M | $804.30M | $802.20M | $822.96M | $802.77M | $805.84M | $799.70M | $803.88M | $790.65M |
| Current liabilities | $206.42M | $188.12M | $193.37M | $170.38M | $195.64M | $213.93M | $198.75M | $192.55M | $197.20M | $209.48M | $209.38M | $216.93M |
| Shareholders' equity | $531.45M | $518.84M | $513.77M | $510.21M | $496.00M | $477.04M | $514.20M | $499.93M | $488.75M | $471.42M | $474.58M | $456.62M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $30.17M | $21.87M | $43.73M | $17.39M | $71.29M | $28.79M | $27.50M | $36.20M | $4.31M | $16.32M | -$26.03M | $49.45M |
| Capital expenditures | $2.07M | $1.63M | $1.40M | $1.38M | $1.34M | $1.36M | $1.74M | $1.43M | $1.40M | $1.31M | $2.20M | $1.43M |
| Free cash flow | $28.10M | $20.24M | $42.33M | $16.01M | $69.96M | $27.43M | $25.76M | $34.78M | $2.91M | $15.01M | -$28.23M | $48.01M |
| Investing cash flow | -$7.22M | -$13.76M | -$11.55M | $8.56M | -$2.75M | -$2.35M | -$14.47M | $21.80M | $288.0K | -$27.75M | $11.72M | -$1.38M |
| Financing cash flow | -$11.70M | -$20.92M | -$26.68M | -$19.60M | -$27.27M | -$7.67M | -$8.78M | -$26.01M | -$6.01M | -$13.00M | $13.97M | -$25.05M |
| Dividends paid | - | - | - | - | - | - | - | - | - | - | - | $0 |
| Share repurchases | $11.74M | $20.93M | $23.96M | $19.60M | $27.27M | $7.67M | $7.04M | $1.01M | $1.01M | $3.00M | $0 | $5.04M |
| Stock-based compensation | $2.94M | $2.82M | $2.76M | $3.12M | $2.60M | $2.54M | $3.74M | $2.34M | $2.23M | $2.11M | $2.48M | $2.19M |
| Depreciation and amortization | $4.06M | $3.52M | $3.81M | $3.87M | $4.03M | $5.00M | $3.88M | $3.60M | $3.77M | $3.68M | $3.53M | $3.78M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 3.3% | 2.7% | 3.4% | 6.6% | 8.5% | 7.6% | 5.7% | 3.3% | 4.1% | 1.8% | 1.5% | -0.0% |
| Net income growth, YoY | -42.1% | - | 51.3% | 162.1% | 206.2% | - | 12.5% | -49.3% | - | - | 31.2% | 49.0% |
| EPS growth, YoY | -39.0% | - | 60.9% | 186.7% | 210.5% | - | 9.5% | -53.1% | - | - | 31.3% | 45.5% |
| Gross margin | 16.8% | 15.9% | 16.4% | 15.4% | 20.8% | 0.6% | 15.2% | 13.4% | 14.8% | 9.7% | 15.2% | 17.6% |
| Net margin | 5.2% | 4.8% | 5.6% | 6.7% | 9.3% | -7.1% | 3.8% | 2.7% | 3.3% | -0.4% | 3.6% | 5.5% |
| Free cash flow margin | 5.9% | 4.3% | 9.1% | 3.4% | 15.1% | 6.0% | 5.8% | 7.9% | 0.7% | 3.5% | -6.7% | 11.3% |
| Current ratio | 2.82 | 3.02 | 3.11 | 3.38 | 2.97 | 2.49 | 2.89 | 2.89 | 2.93 | 2.74 | 2.77 | 2.64 |
Source: XBRL data Healthcare Services Group Inc. files with the SEC, latest filing dated Oct 23, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures and share counts are restated for stock splits the filings show: 3-for-2, first reported Jul 22, 2011.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| HCSG | $1.88B | +4.0% | $104.88M | 5.6% | $1.64B |
| HCA | $78.70B | +5.8% | $6.78B | 8.6% | $103.40B |
| THC | $22.15B | +6.2% | $2.90B | 13.1% | $22.55B |
| EHC | $6.34B | +9.4% | $644.40M | 10.2% | $13.50B |
| UHS | $18.35B | +8.0% | $1.46B | 8.0% | $11.52B |
| ENSG | $5.67B | +17.5% | $399.12M | 7.0% | $10.56B |
| PACS | $5.71B | +11.0% | $277.58M | 4.9% | $7.87B |
| NHC | $1.58B | +5.6% | $115.13M | 7.3% | $3.27B |
| SGRY | $3.37B | +4.0% | -$88.60M | -2.6% | $3.04B |